Solensky Gerald JR 4/A
4/A · Zomedica Pharmaceuticals Corp. · Filed Mar 12, 2019
Insider Transaction Report
Form 4/AAmended
Solensky Gerald JR
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Shares, without par value
2018-10-02$1.89/sh−164$310→ 37,950,936 total
Footnotes (1)
- [F1]The transfer of 164 Common Shares to SEI Private Trust Company on October 2, 2018 was inadvertently omitted from the Form 4 filed by Reporting Person on October 12, 2018. The 164 Common Shares were transferred without Reporting Person's consent and the transfer is currently being contested by Reporting Person.